HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. 2009

Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
Department of Virology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany. barbara_mueller@med.uni-heidelberg.de

Protease inhibitors (PI) act by blocking human immunodeficiency virus (HIV) polyprotein processing, but there is no direct quantitative correlation between the degree of impairment of Gag processing and virion infectivity at low PI concentrations. To analyze the consequences of partial processing, virus particles were produced in the presence of limiting PI concentrations or by co-transfection of wild-type proviral plasmids with constructs carrying mutations in one or more cleavage sites. Low PI concentrations caused subtle changes in polyprotein processing associated with a pronounced reduction of particle infectivity. Dissection of individual stages of viral entry indicated a block in accumulation of reverse transcriptase products, whereas virus entry, enzymatic reverse transcriptase activity, and replication steps following reverse transcription were not affected. Co-expression of low amounts of partially processed forms of Gag together with wild-type HIV generally exerted a trans-dominant effect, which was most prominent for a construct carrying mutations at both cleavage sites flanking the CA domain. Interestingly, co-expression of low amounts of Gag mutated at the CA-SP1 cleavage site also affected processing activity at this site in the wild-type virus. The results indicate that low amounts (<5%) of Gag processing intermediates can display a trans-dominant effect on HIV particle maturation, with the maturation cleavage between CA and SP1 being of particular importance. These effects are likely to be important for the strong activity of PI at concentrations achieved in vivo and also bear relevance for the mechanism of action of the antiviral drug bevirimat.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013386 Succinates Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure. Succinic Acids,Acids, Succinic
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures

Related Publications

Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
October 1989, Cell,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
January 2020, Viruses,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
April 2018, Journal of virology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
October 2012, Journal of virology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
May 2024, Retrovirology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
April 2017, Retrovirology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
July 1993, Journal of virology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
May 1989, The Journal of biological chemistry,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
March 2013, Journal of virology,
Barbara Müller, and Maria Anders, and Hisashi Akiyama, and Sonja Welsch, and Bärbel Glass, and Krisztina Nikovics, and Francois Clavel, and Hanna-Mari Tervo, and Oliver T Keppler, and Hans-Georg Kräusslich
May 2010, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!